Get 50% OFF This Monsoon!
Kerala Ayurveda
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
Unlock Management Data
See Detailed Analysis & Insights
Kerala Ayurveda Ltd was established on 6th July 1992. The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services , cultivation of herbs and maintaining herbarium of medicinal plants. The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam.
The company came out with a public issue in Feb.'95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines. It also envisions setting up a hospital.
A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye. The company is in the midst of enhancing the installed capacity at its Athani plant to produce traditional ayurvedic medicines. Moreover, the company proposes to organise and relocate its twelve clinics to cover all the principal districts in Kerala and augment facilities at its clinics in Bombay, Madras, Bangalore and Mangalore. In addition, it is increasing the bed strength of its hospital in Alwaye.
Kerala Ayurvedic has won the approval of the Karnataka Toursim Development Department to open a health resort at Bangalore catering exclusively to the high income segments, tourists and NRIs.
The company has a well-entrenched presence in several states due to its 75 franchisees and 400 stockists.
During the year 1999-2000, the company exported medicines worth Rs. 56.43 lacs to USA, UK, Italy, Malaysia, Holland and Japan. Four new products have been developed during the year and intial reports are quite encouraging. Clinical studies conducted for patent products have established their efficiency and has also been affirmed by ayurvedic doctors for prescription.
In Bangalore a new Ayurvedic Health resort has started its operation in March 2001 and the trial run had a good response.The company is planning to develop new methods for rare medicinal plants using biofertilizers.
Katra Healthcare Pvt Ltd was merged with Kerala Ayurveda Pharmacy Ltd in 2006 by way of amalgamation and through the said Scheme, the assets and liabilities of Katra Healthcare Pvt Ltd were transferred to and vested in the Company with effect from 1st April 2005. As per Scheme, on 24th Feb 06 the Company allotted 40,00,000 equity shares amounting to Rs.4 Crores to shareholders of Katra Healthcare Pvt Ltd (KHPL). In the ratio of 4 shares for each shares held by them in 'KHPL'.
During year 2007, the Company increased its stake in AyurvedaGram Heritage Wellness Centre Pvt. Ltd., Bangalore from its holding of 15.55% to 74 % by acquiring an additional 58.45% from the erstwhile promoters. Consequently, AyurvedaGram Heritage Wellness Centre Pvt. Ltd (AHWCP) was made subsidiary of the Company. Apart from this, it launched new medicines such as Ostoact for Osteo Arthritis, Menovin for Menopausal syndrome, Laxinol H as Laxative, Ajax for Male Infertility, Pilogest for Piles and Winsoria for Psoriasis. It renovated the Treatment Centre and Kuroor Mana Heritage Building in order to provide better standards and additional amenities. It acquired 3 wholly owned subsidiaries in USA, namely AYU Inc., AYU Natural Medicine Clinics PS and Ayurvedic Academy Inc. During May, 2007, the Company set up a wholly owned overseas subsidiary in Germany named as 'KatraSoft Europe Gmbh' in order to tap the healthcare related software business opportunities in Europe.'
The newly incorporated subsidiary CMS Katra Holdings LLC, USA had picked up a 51% equity stake in US based CMS Katra Nursing LLC, with an objective of acquiring the entire business and assets of CMS Inc., a leading healthcare staffing company based in Florida, USA during 2007-08. The Company during 2008 set up wo more subsidiaries to provide focus on healthcare services, namely CMS Katra Holdings LLC and KatraSoft Europe GmbH. With this, the total no of overseas Subsidiaries increased to five of which four in USA and one in Germany.
During 2008-09, the Company opened new franchise wellness centers at Gurgaon, Jaipur, Noida and Dehradun. In June 2009, a new subsidiary named M/s. NUTRAVEDA Pte. Ltd., was incorporated in Singapore for marketing natural and herbal value added products globally and thereby deliver wellness and nutritional benefits to the global markets. Modern dosage forms of classical formulations were introduced, such as Kashaya to Kashayam Tablets, medicated oils to creams etc. New formulations were introduced for treating diabetes viz. Trikantika Thailam, Kathakhadiradi Kashayam etc. The Company acquired land near Cochin International Airport to setup a new wellness resort.
In 2011-12, the Company started a Panchakarma Center and Pharmacy at Banaras Hindu University under the Private Public Partnership model at the S S Hospital , Varanasi. During 2012-13, it started a Wellness Resort by the side of River Periyar at Aluva under the name, 'Kerala Ayurveda River Retreat' to provide authentic ayurveda treatments. It established a new Treatment Centre at Mangalore to improve the presence in Karnataka. A new Kerala Ayurveda Academy and Wellness Center was started at Fremont in California . A state-of-the-art Ayurveda teaching facility and treatment center was set up to propogate Ayurveda in the USA.
Kerala Ayurveda share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Kerala Ayurveda indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Kerala Ayurveda is valued compared to its competitors.
Kerala Ayurveda PE ratio helps investors understand what is the market value of each stock compared to Kerala Ayurveda 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Kerala Ayurveda evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Kerala Ayurveda generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Kerala Ayurveda in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Kerala Ayurveda shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Kerala Ayurveda compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Kerala Ayurveda over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Kerala Ayurveda helps investors get an insight into when they can enter or exit the stock. Key components of Kerala Ayurveda Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Kerala Ayurveda shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Kerala Ayurveda ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Kerala Ayurveda provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Kerala Ayurveda highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Kerala Ayurveda .
The balance sheet presents a snapshot of Kerala Ayurveda ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.